Missense mutation in a von Willebrand factor type A domain of the alpha 3(VI) collagen gene (COL6A3) in a family with Bethlem myopathy - PubMed (original) (raw)

Missense mutation in a von Willebrand factor type A domain of the alpha 3(VI) collagen gene (COL6A3) in a family with Bethlem myopathy

T C Pan et al. Hum Mol Genet. 1998 May.

Abstract

The Bethlem myopathy is a rare autosomal dominant proximal myopathy characterized by early childhood onset and joint contractures. Evidence for linkage and genetic heterogeneity has been established, with the majority of families linked to 21q22.3 and one large family linked to 2q37, implicating the three type VI collagen subunit genes, COL6A1 (chromosome 21), COL6A2 (chromosome 21) and COL6A3 (chromosome 2) as candidate genes. Mutations of the invariant glycine residues in the triple-helical domain-coding region of COL6A1 and COL6A2 have been reported previously in the chromosome 21-linked families. We report here the identification of a G-->A mutation in the N-terminal globular domain-coding region of COL6A3 in a large American pedigree (19 affected, 12 unaffected), leading to the substitution of glycine by glutamic acid in the N2 motif, which is homologous to the type A domains of the von Willebrand factor. This mutation segregated to all affected family members, to no unaffected family members, and was not identified in 338 unrelated Caucasian control chromosomes. Thus mutations in either the triple-helical domain or the globular domain of type VI collagen appear to cause Bethlem myopathy.

PubMed Disclaimer

Cited by

Collagen VI Muscle Disorders: Mutation Types, Pathogenic Mechanisms and Approaches to Therapy.
Lamandé SR. Lamandé SR. Adv Exp Med Biol. 2021;1348:311-323. doi: 10.1007/978-3-030-80614-9_14. Adv Exp Med Biol. 2021. PMID: 34807426
siRNA-mediated Allele-specific Silencing of a COL6A3 Mutation in a Cellular Model of Dominant Ullrich Muscular Dystrophy.
Bolduc V, Zou Y, Ko D, Bönnemann CG. Bolduc V, et al. Mol Ther Nucleic Acids. 2014 Feb 11;3(2):e147. doi: 10.1038/mtna.2013.74. Mol Ther Nucleic Acids. 2014. PMID: 24518369 Free PMC article.
What can we learn from common variants associated with unexpected phenotypes in rare genetic diseases?
Erdmann J. Erdmann J. Orphanet J Rare Dis. 2021 Jan 21;16(1):41. doi: 10.1186/s13023-021-01684-w. Orphanet J Rare Dis. 2021. PMID: 33478553 Free PMC article.
Assignment of a form of congenital muscular dystrophy with secondary merosin deficiency to chromosome 1q42.
Brockington M, Sewry CA, Herrmann R, Naom I, Dearlove A, Rhodes M, Topaloglu H, Dubowitz V, Voit T, Muntoni F. Brockington M, et al. Am J Hum Genet. 2000 Feb;66(2):428-35. doi: 10.1086/302775. Am J Hum Genet. 2000. PMID: 10677302 Free PMC article.
The collagen VI-related myopathies: muscle meets its matrix.
Bönnemann CG. Bönnemann CG. Nat Rev Neurol. 2011 Jun 21;7(7):379-90. doi: 10.1038/nrneurol.2011.81. Nat Rev Neurol. 2011. PMID: 21691338 Free PMC article. Review.

Missense mutation in a von Willebrand factor type A domain of the alpha 3(VI) collagen gene (COL6A3) in a family with Bethlem myopathy - PubMed (original) (raw)